Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Quality of Life After Hyperbaric Oxygen Therapy in Post-COVID Patients

NCT06159309 is registered in ClinicalTrials.gov with Rutger Lalieu as lead sponsor.

NCT NCT06159309
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06159309 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Quality of Life After Hyperbaric Oxygen Therapy in Post-COVID Patients
Lead sponsor
Rutger Lalieu
Phase
Observational
Overall status
Active, not recruiting
Start date
February 6, 2023
Completion date
August 31, 2025
Enrollment
200 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

long covid, long covid 19, long covid-19 syndrome, long covid19